Neurointerventional Devices Market
Market Insights on Neurointerventional Devices covering sales outlook, demand forecast & up-to-date key trends
Neurointerventional Devices Market By Product (Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Embolic Protection Devices, Flow Diverters Devices, Intrasaccular Devices, Liquid Embolic, Balloons and Stent Retrievers), Technique (Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures, Flow Disruption) & Region - Forecast 2022 - 2030
Neurointerventional Devices Market Snapshot (2022-2030)
[223 Pages Report] Global neurointerventional devices market is expected to project a significant growth CAGR value of about 4.7% from 2022 to 2030, with an estimated market value of around US$ 2.5 Bn as of 2022. As per Future Market Insights’ projections, hospitals hold a substantial share of over 90.4% by end user in 2021 within the global market.
|
Data Points |
Market Insights |
|
Market Value 2021 |
US$ 2.4 Bn |
|
Market Value 2022 |
US$ 2.5 Bn |
|
Market Value 2030 |
US$ 3.6 Bn |
|
CAGR 2022-2030 |
4.7% |
|
Market Share of Top 5 Countries |
72.5% |
|
Key Market Players |
Stryker Corporation, Penumbra Inc., Covidien Public Limited, Johnson & Johnson Private Limited and Terumo Corporation |
The market effectiveness of neurointerventional devices depends upon the pathway elected by the regional or international players for regulatory approval within the neurotechnological domain. The ingrained safety and efficacy of such medical devices with a varied range of degrees of scientific and clinical ambiguity exhibit a probable benefit and safety to the patient, in order for the potentially life-saving treatments to be able to reach the marketplace.
The rising concentrative efforts by the medical device manufacturers for the development and safety of neurointerventional devices followed by such procedural guidelines for use in healthcare settings determine the growth potential in association with neurointerventional devices market.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
4.65% |
|
H1, 2022 Projected |
4.72% |
|
H1, 2022 Outlook |
4.12% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 60 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 53 ↓ |
According to Future Market Insights' analysis, the global neurointerventional devices market expects to drop by 53 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 Projected value, the market during H1-2022 outlook period will show a dip of 60 BPS.
The direct and indirect high cost of the devices and procedure as well as stringent regulations are some of primary limitations associated with this drop in the BPS values. The market is subject to regulatory requirements, as per the macro and industry standards.
Primary drivers which could propel the market growth include the integration of automated systems as well as virtual reality within existing device systems for greater efficacy. Market players have developed intensive activities focused upon novel product launches in order to maintain their geographical as well as market outreach.
The key developments in the market include the FDA clearance of NeuroVasc’s Envi-SR Stent-Retriever Device for the treatment of ischemic stroke in randomized control trials.
Sales Analysis Of Neurointerventional Devices From 2015 To 2021 Vs Market Outlook For 2022 To 2030
The neurointerventional devices market holds nearly 27.0% of the overall US$ 8.9 Bn neurology devices market in 2021.
The procedure of neurointervention utilizes approaches which are minimally-invasive and catheter based for the treatment of specific diseases encompassing the blood vessels in the head, neck and the spine.
The neurointerventional devices market is set to project growth in terms of sales and adoption through the forecasted period owing to their applications in the management of several commonly treated health conditions including brain aneurysms, vascular malformation of the brain or spine, stroke, carotid artery diseases, and others.
Several neurointerventional devices such as embolic coils, neurovascular stents, aneurysm clips and support devices also find useful applications within the neurosurgical platforms. This is reinforced by the rising prevalence of neurovascular diseases like traumatic brain injuries, and is thus expected to elevate the market growth value of neurointerventional devices market towards the end of the forecast period 2030.
As per the Institute for Health Metrics and Evaluation annual updates of the GBD study in 2019, “Globally, in 2016, neurological disorders were the leading cause of disability-adjusted life year and second leading cause of deaths.” Additionally, as per the Journal of Neurosurgery (2019), about and estimate of 69 Mn people around the globe suffer from traumatic brain injuries every year.
This consistent and high volume of patient metrics recorded within healthcare facilities for vascular diseases thus proves relevant in resulting towards an increase in the demand for neurointerventional devices market around the globe.
Moreover, factors involving the growing patient population, advancements within the product development hemisphere, provision of medical reimbursements for neurological procedures as well as the expansion of the healthcare infrastructure within the emerging nations further promote the positive sales outlook of the neurointerventional devices market.
Likewise, actively increasing research in the field of neurovascular therapies combined with the rising demand for minimally invasive medical procedures and rising awareness among medical professionals regarding minimally invasive surgical procedures presents high prospects for growth for the neurointerventional devices market throughout the forecast period.
The market is expected to expand at a considerable growth rate over the next eight years at a CAGR of close to 4.7%, and offer an absolute $ opportunity of US$ 110.5 Mn from 2022-2023. The above mentioned factors compile the sales outlook of the global neurointerventional devices market, and are expected to raise value in the overall healthcare industry.
What Are The Key Opportunities For Neurointerventional Devices Manufacturers?
The key opportunities that the neurointerventional devices market may potentially benefit from, include the increasing research activities by neurosurgeons and other medical professionals for therapeutic alternatives which can aid to the patients by promoting low risk of mortality or severity of neurovascular diseases in patients.
Additionally, the rising volume of patient pool within the neurovascular ailments sphere as well as the severity of medical conditions such as haemorrhage or infections in the patients will promote the adoption of minimally-invasive neurointerventional device aided procedures, thus stimulating the growth of the neurointerventional devices market throughout the forecasted period.
Increasing demand for minimally invasive neurosurgical procedures proposes noteworthy clinical advantages over conventional surgical procedures, and include aspects such as shorter in-patient stay within the hospital facility, quicker patient recovery, greater procedural safety and efficiency, and greater affordability.
Thus, the market acceptance and demand for minimally invasive surgical procedures is budding among medical professionals across the world, encouraging a boost in the growth of the neurointerventional devices market.
Additionally, the factor of aging heaves towards the prevalence of adverse thrombotic events like pulmonary embolism, epilepsy, and stroke, which can call for neurosurgical interventions. Thus, the rising geriatric population and demand for minimally invasive procedures are expected to offer significant growth opportunities for established as well as developing industry players in the field of neurointerventional devices market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat Are The Factors Restraining Demand For Neurointerventional Devices?
The restraints which affect the growth of the neurointerventional devices market comprise of direct and indirect costs of devices and procedures as well as the presence of rigid regulations related to medical device safety. Additionally, repeated product recalls and elevated costs associated with neurointerventional devices are expected to obstruct the market growth during the forecast period.
Moreover, increasing product developments with innovative and novel properties resulting in increased cost of neuro-interventional devices adds to the hindrance of higher adoption of neurointerventional devices, and thus plays as a restraint for the growth of the neurointerventional devices market. The high cost associated with devices leads to increased treatment cost, thus rendering patients with nervous-system associated disorders to pay exorbitant costs, displaying unaffordability.
Within the mature markets, such as the U.S., the developmental pipeline for neurointerventional products is hampered chiefly by the pressure of pricing encountered by the key producers as a consequence of unsupportive government reforms.
Country-Wise Insights
What Makes the U.S. the Largest Market for Neurointerventional Devices?
The U.S. dominates the North American region with a total market share of about 82.4% in 2021, and is projected to continue experiencing high growth throughout the forecast period.
The U.S. healthcare system supports various reimbursement policies within the medical device domain, and thus promotes wider applications of neurointerventional devices within the healthcare facilities under a determined cost bracket or subsidized costs, ensuring lesser patient spending and enhanced patient treatment outcomes.
Why is France Considered a Lucrative Market for Neurointerventional Devices in Western Europe?
France is set to exhibit a CAGR of about 2.6% in the Western Europe neurointerventional devices market during the forecast period. The expansion of major players into the region, such as the Stryker Corporation, with their product “Surpass Evolve Flow Diverter” into the European market in 2019, before their product launch into the U.S. market in 2020 aided in the higher market share of the country within the Western Europe region.
What is the Outlook for Japan Regarding Neurointerventional Devices?
In 2021, Japan held a 14.4% share in the global neurointerventional devices market, and is projected to expand at a CAGR of 3.6% from 2022 to 2030. Japan has a large number of geriatric population, and with it, a rising concern towards the management of chronic diseases.
The higher prevalence of neurodegenerative disorders in the country linked with a large geriatric population promote the growth of the Japan neurointerventional devices market, and this trend is expected to follow throughout the forecast period.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-Wise Insights
Which Neurointerventional Devices Product is Driving Market Growth?
Embolic coils project a lucrative growth at a CAGR of 3.7% till the end of the forecast period, with a market share of over 35.1% in 2021. Embolic coiling promotes minimally invasive surgical procedures for the treatment of cerebral aneurysms and fistulas, the most widely occurring trauma associated fatalities.
Which Technique Holds a Dominant Stance in the Global Neurointerventional Devices Market?
Coiling procedures hold a revenue share of 42.7% in 2021 and are projected to hold a share over the forecast period with the estimation being 40.5%. Coiling procedures are essentially helpful during endovascular procedures. The higher adoption and market value of coiling procedures are associated with their use in alternate methods of surgery or intervention for diseases such as brain aneurysms.
Which End User is More Lucrative in the Global Neurointerventional Devices Market?
Hospitals project a large value of market share of about 90.4% in the global neurointerventional devices market in 2021. Hospitals are expected to project a growth CAGR of 4.8% by the end of the forecast period.
With rising incidence of neurological disorders, the patient pool for various neuro-associated diseases approach healthcare facilities, chiefly the hospitals, within which the devices associated with indication specific treatments have been incorporated and managed by skilled professionals for routine medical interventions.
Competitive Landscape
Key players in the market are focusing on strengthening their position in the market space by offering a diverse array of products in their portfolio. Collaborative efforts to maintain market position as well as establishing their geographical presence through a strong distribution network are more strategies observed in the key market players for neurointerventional devices.
- In January 2022, Stryker announced definitive agreement to acquire Vocera Communications, which has emerged as a leading platform in the digital care coordination and communication category.
- In July 2021, CERENOVUS, showcased its latest innovations in stroke care at the Society of NeuroInterventional Surgery (SNIS) 2021 annual meeting. CERENOVUS announced new data during poster sessions and feature innovations across its ischemic and hemorrhagic portfolios that reflect the company’s continued commitment to changing the trajectory of stroke.
Similarly, recent developments related to companies manufacturing Neurointerventional Devices products have been tracked by the team at Future Market Insights, which are available in the full report.
Report Scope As Per Neurointerventional Devices Industry Analysis
|
Attribute |
Details |
|
Forecast Period |
2022-2030 |
|
Historical Data Available for |
2013-2021 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Western Europe, Eastern Europe, Japan, APEJ and Middle East and Africa |
|
Key Countries Covered |
U.S., Canada, Brazil, Mexico, Germany, France, U.K., Italy, Spain, Nordic, BENELUX, Russia, Poland, Japan, China, India, ASEAN, ANZ, Rest of Asia Pacific, GCC Countries, North Africa and South Africa |
|
Key Market Segments Covered |
Product, Technique, End User and Region |
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Market Segments Covered In Neurointerventional Devices Industry Research
By Product:
- Embolic Coils
- Carotid Stents
- Intracranial Stents
- Neurovascular Thrombectomy
- Embolic Protection Devices
- Flow Diverters Devices
- Intrasaccular Devices
- Liquid Embolic
- Balloons
- Stent Retrievers
By Technique:
- Neurothrombectomy Procedure
- Cerebral Angiography
- Stenting
- Coiling Procedures
- Flow Disruption
By End User:
- Hospitals
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Japan
- APEJ
- Middle East and Africa (MEA)
Frequently Asked Questions
The global neurointerventional devices market is worth US$ 2.4 Bn at present, and is set to expand 1.4X over the next eight years.
The neurointerventional devices market is expected to reach US$ 3.6 Bn by the end of 2030, with sales revenue expected to register 4.7% CAGR.
Increasing number of strategic alliances and new product developments are some of the key trends being witnessed in this marketplace.
The U.S., Japan, China, Canada and Brazil are expected to drive demand for neurointerventional devices.
North America is one of the key markets for neurointerventional devices, with the U.S. expected to account over 76.8% of the North American market revenue share by the end of 2030.
Demand for neurointerventional devices in Western Europe is expected to register growth of 4.3% over the next eight years.
The U.S., China and Japan are key producers of neurointerventional devices products.
Stryker Corporation, Penumbra Inc., Covidien Public Limited, Johnson & Johnson Private Limited and Terumo Corporation are the key exporters of neurointerventional devices market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. End User Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Advancements and Latest Innovations in Neurointerventional Devices
3.3. Latest Market Consolidation Activities
4. Key Success Factors
4.1. Technique Adoption / Usage Analysis
4.2. Key Strength Features and their USPs
4.3. Key Promotional Strategies, By Manufacturers
4.4. Key Regulations, By Region
4.5. Key Statistics on Disease Epidemiology Key Statistics, By Region
5. Global Market - Pricing Analysis
5.1. Regional Pricing Analysis By Product Type
5.2. Pricing Break-up
5.2.1. Manufacturer Level Pricing
5.2.2. Distributor Level Pricing
5.3. Global Average Pricing Analysis Benchmark
6. Global Market Demand (in Volume or in Units) Analysis 2013-2021 and Forecast, 2022-2030
6.1. Historical Market Volume (in Units) Analysis, 2013-2021
6.2. Current and Future Market Volume (in Units) Projections, 2022-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2013-2021 and Forecast, 2022-2030
7.1. Historical Market Value (US$ Mn) Analysis, 2013-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Global GDP Growth Outlook
8.1.2. Global Healthcare Expenditure Outlook
8.1.3. Global Parent Market Outlook
8.2. Forecast Factors - Relevance & Impact
8.2.1. Increasing Number of Brain Aneurysm Cases
8.2.2. Increasing Incidence of Ischemic Strokes
8.2.3. Rise in Number of Traumatic Brain Injuries (TBI)
8.2.4. Increase in Adoption Rate of Nuerointerventional Devices
8.2.5. New Product Developments
8.3. Value Chain
8.4. Market Dynamics
8.4.1. Drivers
8.4.2. Restraints
8.4.3. Opportunity Analysis
9. COVID19 Crisis Analysis
9.1. Current COVID19 Statistics and Probable Future Impact
9.2. Current GDP Projection and Probable Impact
9.3. Current Economic Projection as compared to 2008 financial analysis
9.4. COVID19 and Impact Analysis
9.4.1. Revenue By Product Type
9.4.2. Revenue By Technique
9.4.3. Revenue By Country
9.5. 2022 Market Scenario
9.6. Quarter by Quarter Forecast
9.7. Projected recovery Quarter
9.8. Recovery Scenario – Short term, Midterm and Long Term Impact
10. Global Market Analysis 2013-2021 and Forecast 2022-2030, by Product Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2013 - 2021
10.3. Current and Future Market Size (US$ Mn) and Forecast By Product Type, 2022 - 2030
10.3.1. Embolic Coils
10.3.2. Intracranial Stents
10.3.3. EPD
10.3.4. Intrasaccular
10.3.5. Balloons
10.3.6. Carotid Stents
10.3.7. Thrombectomy
10.3.8. Flow Diverters
10.3.9. Liquid Embolics
10.3.10. Stent Retrievers
10.4. Market Attractiveness Analysis By Product Type
11. Global Market Analysis 2013-2021 and Forecast 2022-2030, by Technique
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) and Volume Analysis By Technique, 2013 - 2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique, 2022 - 2030
11.3.1. Neurothrombectomy Procedure
11.3.2. Stenting
11.3.3. Cerebral Angiography
11.3.4. Coiling Procedure
11.3.5. Flow Disruption
11.4. Market Attractiveness Analysis By Technique
12. Global Market Analysis 2013-2021 and Forecast 2022-2030, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis by End User, 2013 - 2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022 - 2030
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centres
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2013-2021 and Forecast 2022-2030, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis by Region, 2013 - 2021
13.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2022 - 2030
13.3.1. North America
13.3.2. Latin America
13.3.3. Western Europe
13.3.4. Middle East and Africa (MEA)
13.3.5. Eastern Europe
13.3.6. APEJ
13.3.7. Japan
13.4. Market Attractiveness Analysis by Region
14. North America Market Analysis 2013-2021 and Forecast 2022-2030
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2013 - 2021
14.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.2. By Product Type
14.4.3. By Technique
14.4.4. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Technique
14.5.4. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Latin America Market 2013-2021 and Forecast 2022-2030
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2013 - 2021
15.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Mexico
15.4.1.3. Rest of Latin America
15.4.2. By Product Type
15.4.3. By Technique
15.4.4. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Technique
15.5.4. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Western Europe Market 2013-2021 and Forecast 2022-2030
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2013 - 2021
16.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. France
16.4.1.3. U.K.
16.4.1.4. Italy
16.4.1.5. Spain
16.4.1.6. Nordic
16.4.1.7. BENELUX
16.4.1.8. Rest of Western Europe
16.4.2. By Product Type
16.4.3. By Technique
16.4.4. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Technique
16.5.4. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. APEJ Market 2013-2021 and Forecast 2022-2030
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2013 - 2021
17.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030
17.4.1. By Country
17.4.1.1. China
17.4.1.2. India
17.4.1.3. ASEAN
17.4.1.4. ANZ
17.4.1.5. Rest of Asia Pacific
17.4.2. By Product Type
17.4.3. By Technique
17.4.4. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product Type
17.5.3. By Technique
17.5.4. By End User
17.6. Market Trends
17.7. Key Market Participants - Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
18. Eastern Europe Market 2013-2021 and Forecast 2022-2030
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2013 - 2021
18.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030
18.4.1. By Country
18.4.1.1. Russia
18.4.1.2. Poland
18.4.1.3. Rest of Europe
18.4.2. By Product Type
18.4.3. By Technique
18.4.4. By End User
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product Type
18.5.3. By Technique
18.5.4. By End User
18.6. Market Trends
18.7. Key Market Participants - Intensity Mapping
18.8. Drivers and Restraints - Impact Analysis
19. Japan Market 2013-2021 and Forecast 2022-2030
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2013 - 2021
19.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030
19.4.1. By Country
19.4.2. By Product Type
19.4.3. By Technique
19.4.4. By End User
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product Type
19.5.3. By Technique
19.5.4. By End User
19.6. Market Trends
19.7. Key Market Participants - Intensity Mapping
19.8. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market 2013-2021 and Forecast 2022-2030
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2013 - 2021
20.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2022 - 2030
20.4.1. By Country
20.4.1.1. GCC Countries
20.4.1.2. South Africa
20.4.1.3. Rest of Middle East and Africa
20.4.2. By Product Type
20.4.3. By Technique
20.4.4. By End User
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Product Type
20.5.3. By Technique
20.5.4. By End User
20.6. Market Trends
20.7. Key Market Participants - Intensity Mapping
20.8. Drivers and Restraints - Impact Analysis
21. Emerging & Key Countries Market Analysis
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.2. U.S. Market Analysis
21.2.1. By Product Type
21.2.2. By Technique
21.2.3. By End User
21.3. Canada Market Analysis
21.3.1. By Product Type
21.3.2. By Technique
21.3.3. By End User
21.4. Mexico Market Analysis
21.4.1. By Product Type
21.4.2. By Technique
21.4.3. By End User
21.5. Brazil Market Analysis
21.5.1. By Product Type
21.5.2. By Technique
21.5.3. By End User
21.6. Germany Market Analysis
21.6.1. By Product Type
21.6.2. By Technique
21.6.3. By End User
21.7. Italy Market Analysis
21.7.1. By Product Type
21.7.2. By Technique
21.7.3. By End User
21.8. France Market Analysis
21.8.1. By Product Type
21.8.2. By Technique
21.8.3. By End User
21.9. U.K. Market Analysis
21.9.1. By Product Type
21.9.2. By Technique
21.9.3. By End User
21.10. Spain Market Analysis
21.10.1. By Product Type
21.10.2. By Technique
21.10.3. By End User
21.11. BENELUX Market Analysis
21.11.1. By Product Type
21.11.2. By Technique
21.11.3. By End User
21.12. Russia Market Analysis
21.12.1. By Product Type
21.12.2. By Technique
21.12.3. By End User
21.13. China Market Analysis
21.13.1. By Product Type
21.13.2. By Technique
21.13.3. By End User
21.14. Japan Market Analysis
21.14.1. By Product Type
21.14.2. By Technique
21.14.3. By End User
21.15. S. Korea Market Analysis
21.15.1. By Product Type
21.15.2. By Technique
21.15.3. By End User
21.16. India Market Analysis
21.16.1. By Product Type
21.16.2. By Technique
21.16.3. By End User
21.17. ASEAN Market Analysis
21.17.1. By Product Type
21.17.2. By Technique
21.17.3. By End User
21.18. Australia and New Zealand Market Analysis
21.18.1. By Product Type
21.18.2. By Technique
21.18.3. By End User
21.19. GCC Countries Market Analysis
21.19.1. By Product Type
21.19.2. By Technique
21.19.3. By End User
21.20. Turkey Market Analysis
21.20.1. By Product Type
21.20.2. By Technique
21.20.3. By End User
21.21. South Africa Market Analysis
21.21.1. By Product Type
21.21.2. By Technique
21.21.3. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Concentration
22.3. Market Share Analysis of Top Players
22.4. Market Presence Analysis
22.4.1. By Regional Footprint of Players
22.4.2. Product Footprint by Players
22.4.3. Channel Footprint by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Pricing Analysis by Competition
23.3. Competition Benchmarking
23.4. Competition Deep Dive
23.5. Key Players Based On Estimated Tracked Revenue
23.5.1. Stryker Corporation
23.5.1.1. Product Type Portfolio
23.5.1.1.1. Profitability by Market Segments (Channel/Region)
23.5.1.1.2. Sales Footprint
23.5.1.1.3. Analyst commentary
23.5.1.1.4. Strategy Overview
23.5.1.1.4.1. Marketing Strategy
23.5.1.1.4.2. Product Strategy
23.5.1.1.4.3. Channel Strategy
23.5.2. Penumbra Inc.
23.5.2.1. Product Type Portfolio
23.5.2.1.1. Profitability by Market Segments (Channel/Region)
23.5.2.1.2. Sales Footprint
23.5.2.1.3. Analyst commentary
23.5.2.1.4. Strategy Overview
23.5.2.1.4.1. Marketing Strategy
23.5.2.1.4.2. Product Strategy
23.5.2.1.4.3. Channel Strategy
23.5.3. Covidien Public Limited
23.5.3.1. Product Type Portfolio
23.5.3.1.1. Profitability by Market Segments (Channel/Region)
23.5.3.1.2. Sales Footprint
23.5.3.1.3. Analyst commentary
23.5.3.1.4. Strategy Overview
23.5.3.1.4.1. Marketing Strategy
23.5.3.1.4.2. Product Strategy
23.5.3.1.4.3. Channel Strategy
23.5.4. Johnson & Johnson Private Limited
23.5.4.1. Product Type Portfolio
23.5.4.1.1. Profitability by Market Segments (Channel/Region)
23.5.4.1.2. Sales Footprint
23.5.4.1.3. Analyst commentary
23.5.4.1.4. Strategy Overview
23.5.4.1.4.1. Marketing Strategy
23.5.4.1.4.2. Product Strategy
23.5.4.1.4.3. Channel Strategy
23.5.5. Terumo Corporation
23.5.5.1. Product Type Portfolio
23.5.5.1.1. Profitability by Market Segments (Channel/Region)
23.5.5.1.2. Sales Footprint
23.5.5.1.3. Analyst commentary
23.5.5.1.4. Strategy Overview
23.5.5.1.4.1. Marketing Strategy
23.5.5.1.4.2. Product Strategy
23.5.5.1.4.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value Forecast by Product; 2013-2030 (US$ Mn)
Table 2: Global Market Volume Forecast by Product; 2013-2030
Table 3: Global Market Value Forecast by Technique; 2013-2030 (US$ Mn)
Table 4: Global Market Volume Forecast by Technique; 2013-2030
Table 5: Global Market Value Forecast by End Use; 2013-2030 (US$ Mn)
Table 6: North America Market Value Forecast by Product; 2013-2030 (US$ Mn)
Table 7: North America Market Volume Forecast by Product; 2013-2030
Table 8: North America Market Value Forecast by End Use; 2013-2030 (US$ Mn)
Table 9: North America Market Value Forecast by Technique; 2013-2030 (US$ Mn)
Table 10: North America Market Volume Forecast by Technique; 2013-2030
Table 11: North America Market Value Forecast By Country; 2013-2030
Table 12: North America Market Volume Forecast By Country; 2013-2030
Table 13: Latin America Market Value Forecast by Product; 2013-2030 (US$ Mn)
Table 14: Latin America Market Volume Forecast by Product; 2013-2030
Table 15: Latin America Market Value Forecast by End Use; 2013-2030 (US$ Mn)
Table 16: Latin America Market Value Forecast by Technique; 2013-2030 (US$ Mn)
Table 17: Latin America Market Volume Forecast by Technique; 2013-2030
Table 18: Latin America Market Value Forecast by Country; 2013-2030 (US$ Mn)
Table 19: Latin America Market Volume Forecast by Country; 2013-2030
Table 20: Western Europe Market Value Forecast by Product; 2013-2030 (US$ Mn)
Table 21: Western Europe Market Volume Forecast by Product; 2013-2030
Table 22: Western Europe Market Value Forecast by End Use; 2013-2030 (US$ Mn)
Table 23: Western Europe Market Value Forecast by Technique; 2013-2030 (US$ Mn)
Table 24: Western Europe Market Volume Forecast by Technique; 2013-2030
Table 25: Western Europe Market Value Forecast by Country; 2013-2030 (US$ Mn)
Table 26: Western Europe Market Volume Forecast by Country; 2013-2030
Table 27: Eastern Europe Market Value Forecast by Product; 2013-2030 (US$ Mn)
Table 28: Eastern Europe Market Volume Forecast by Product; 2013-2030
Table 29: Eastern Europe Market Value Forecast by End Use; 2013-2030 (US$ Mn)
Table 30: Eastern Europe Market Value Forecast by Technique; 2013-2030 (US$ Mn)
Table 31: Eastern Europe Market Volume Forecast by Technique; 2013-2030
Table 32: Eastern Europe Market Value Forecast by Country; 2013-2030
Table 33: Eastern Europe Market Volume Forecast by Country; 2013-2030
Table 34: APEJ Market Value Forecast by Product; 2013-2030 (US$ Mn)
Table 35: APEJ Market Volume Forecast by Product; 2013-2030
Table 36: APEJ Market Value Forecast by End Use; 2013-2030 (US$ Mn)
Table 37: APEJ Market Value Forecast by Technique; 2013-2030 (US$ Mn)
Table 38: APEJ Market Volume Forecast by Technique; 2013-2030 (Units)
Table 39: APEJ Market Value Forecast by Country; 2013-2030 (US$ Mn)
Table 40: APEJ Market Volume Forecast by Country; 2013-2030 (Units)
Table 41: MEA Market Value Forecast by Product; 2013-2030 (US$ Mn)
Table 42: MEA Market Volume Forecast by Product; 2013-2030
Table 43: MEA Market Value Forecast by End Use; 2013-2030 (US$ Mn)
Table 44: MEA Market Value Forecast by Technique; 2013-2030 (US$ Mn)
Table 45: MEA Market Volume Forecast by Technique; 2013-2030
Table 46: MEA Market Value Forecast by Country; 2013-2030 (US$ Mn)
Table 47: MEA Market Volume Forecast by Country; 2013-2030
Table 48: Japan Market Value Forecast by Product; 2013-2030 (US$ Mn)
Table 49: Japan Market Volume Forecast by Product; 2013-2030
Table 50: Japan Market Value Forecast by End Use; 2013-2030 (US$ Mn)
Table 51: Japan Market Value Forecast by Technique; 2013-2030 (US$ Mn)
Table 52: Japan Market Volume Forecast by Technique; 2013-2030 (Units)
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Represents global devices market during the forecast period.
Figure 02: Global Market Value Share & BPS Analysis By Product, 2013, 2021 & 2030 (%)
Figure 03: Attractiveness Index By Technique
Figure 04: Global Devices Y-o-Y Growth By Technique, 2013–2030
Figure 05: Global Market (Mn) & Y-o-Y Growth (%) By Embolic Coils, 2013–2030
Figure 06: Global Market Volume & Y-o-Y Growth (%) By Embolic Coils, 2013–2030
Figure 07: Devices Market Absolute $ Opportunity By Embolic Coils Segment, 2013–2030 (US$ Mn)
Figure 08: Global Market (Mn) & Y-o-Y Growth (%) By Carotid Stents, 2013–2030
Figure 09: Global Market Volume By Carotid Stents, 2013–2030
Figure 10: Global Devices Market Absolute $ Opportunity By Carotid Stents Segment, 2013–2030 (US$ Mn)
Figure 11: Global Market (US$ Mn) & Y-o-Y Growth (%) By Intracranial Stents, 2013–2030
Figure 12: Global Market Volume & Y-o-Y Growth (%) By Intracranial Stents, 2013–2030
Figure 13: Global Devices Market Absolute $ Opportunity By Intracranial Stents Segment, 2013–2030 (US$ Mn)
Figure 14: Global Market (US$ Mn) & Y-o-Y Growth (%) By Neurovascular Thrombectomy, 2013–2030
Figure 15: Global Market Volume & Y-o-Y Growth (%) By Neurovascular Thrombectomy, 2013–2030
Figure 16: Global Devices Market Absolute $ Opportunity By Neurovascular Thrombectomy Segment, 2013–2030 (US$ Mn)
Figure 17: Global Market (US$ Mn) & Y-o-Y Growth (%) By Embolic Protection Devices, 2013–2030
Figure 18: Global Market Volume & Y-o-Y Growth (%) By Embolic Protection Devices, 2013–2030
Figure 19: Global Devices Market Absolute $ Opportunity By Embolic Protection Devices Segment, 2013–2030 (US$ Mn)
Figure 20: Global Market (US$ Mn) & Y-o-Y Growth (%) By Flow Diverters Devices, 2013–2030
Figure 21: Global Market Volume & Y-o-Y Growth (%) By Flow Diverters Devices, 2013–2030
Figure 22:Global Devices Market Absolute $ Opportunity By Flow Diverters Devices Segment, 2013–2030 (US$ Mn)
Figure 23: Global Market (US$ Mn) & Y-o-Y Growth (%) By Intrasaccular Devices, 2013–2030
Figure 24: Global Market Volume & Y-o-Y Growth (%) By Intrasaccular Devices, 2013–2030
Figure 25: Global Devices Market Absolute $ Opportunity By Intrasaccular Devices Segment, 2013–2030 (US$ Mn)
Figure 26: Global Market (US$ Mn) & Y-o-Y Growth (%) By Liquid Embolic, 2013–2030
Figure 27: Global Market Volume & Y-o-Y Growth (%) By Liquid Embolic, 2013–2030
Figure 28: Global Devices Market Absolute $ Opportunity By Liquid Embolic Segment, 2013–2030 (US$ Mn)
Figure 29: Global Market (Mn) & Y-o-Y Growth (%) By Balloons, 2013–2030
Figure 30: Global Market Volume & Y-o-Y Growth (%) By Balloons, 2013–2030
Figure 31: Global Devices Market Absolute $ Opportunity By Balloons Segment, 2013–2030 (US$ Mn)
Figure 32: Global Market (Mn) & Y-o-Y Growth (%) By Stent Retrievers, 2013–2030
Figure 33: Global Market Volume & Y-o-Y Growth (%) By Stent Retrievers, 2013–2030
Figure 34: Global Devices Market Absolute $ Opportunity By Stent Retrievers Segment, 2013–2030 (US$ Mn)
Figure 36: Attractiveness Index By Technique
Figure 37: Global Devices Y-o-Y Growth By Technique, 2013–2030
Figure 38: Global Market (US$ Mn) & Y-o-Y Growth (%) By Neurothrombectomy Procedure, 2013–2030
Figure 39: Global Market Volume & Y-o-Y Growth (%) By Neurothrombectomy Procedure, 2013–2030
Figure 40: Devices Market Absolute $ Opportunity by Neurothrombectomy Procedure Segment, 2013–2030 (US$ Mn)
Figure 41: Global Market (Mn) & Y-o-Y Growth (%) By Cerebral Angiography, 2013–2030
Figure 42: Global Market Volume & Y-o-Y Growth (%) By Cerebral Angiography, 2013–2030
Figure 43: Devices Market Absolute $ Opportunity by Cerebral Angiography Segment, 2013–2030 (US$ Mn)
Figure 44: Global Market (Mn) & Y-o-Y Growth (%) By Stenting, 2013–2030
Figure 45: Global Market Volume & Y-o-Y Growth (%) By Stenting, 2013–2030
Figure 46: Devices Market Absolute $ Opportunity by Stenting Segment, 2013–2030 (US$ Mn)
Figure 47: Global Market (Mn) & Y-o-Y Growth (%) By Coiling Procedures, 2013–2030
Figure 48: Global Market Volume & Y-o-Y Growth (%) By Coiling Procedure, 2013–2030
Figure 50: Global Market (Mn) & Y-o-Y Growth (%) By Flow Disruption, 2013–2030
Figure 51: Global Market Volume & Y-o-Y Growth (%) By Flow Disruption, 2013–2030
Figure 54: Attractiveness Index By End-user
Figure 55: Global Devices Y-o-Y Growth By End-user, 2013–2030
Figure 56: Global Market (Mn) & Y-o-Y Growth (%) By Hospitals, 2013–2030
Figure 57: Global Market Absolute $ Opportunity By Hospitals, 2013–2030 (US$ Mn)
Figure 58: Global Market (Mn) & Y-o-Y Growth (%) By Ambulatory Surgical Centres, 2013–2030
Figure 59: Global Market Absolute $ Opportunity By Ambulatory Surgical Centres, 2013–2030 (US$ Mn)
Figure 60: Global Devices Market Value Share By Region (%), 2013, 2021 & 2030
Figure 61: Attractiveness Index By Region
Figure 62: Global Devices Y-o-Y Growth By Region, 2013–2030
Figure 63: North America Devices Market Value Forecast (US$ Mn), By Region, 2013–2030
Figure 64: North America Devices Market Volume & Y-o-Y Growth (%) Forecast (Units), By Region, 2013–2030
Figure 65: North America Devices Market Absolute $ Opportunity, 2013–2030 (US$ Mn)
Figure 66: Latin America Devices Market Value Forecast (US$ Mn), By Region, 2013–2030
Figure 67: Latin America Devices Market Volume & Y-o-Y Growth (%) Forecast (Units), By Region, 2013–2030
Figure 68: Latin America Devices Market Absolute $ Opportunity, 2013–2030 (US$ Mn)
Figure 69: Western Europe Devices Market Value Forecast (US$ Mn), By Region, 2013–2030
Figure 70: Western Europe Devices Market Volume & Y-o-Y Growth (%) Forecast (Units), By Region, 2013–2030
Figure 71: Western Europe Devices Market Absolute $ Opportunity, 2013–2030 (US$ Mn)
Figure 72: Eastern Europe Devices Market Value Forecast (US$ Mn), By Region, 2013–2030
Figure 73: Eastern Europe Devices Market Volume & Y-o-Y Growth (%) Forecast (Units), By Region, 2013–2030
Figure 74: Eastern Europe Devices Market Absolute $ Opportunity, 2013–2030 (US$ Mn)
Figure 75: APEJ Devices Market Value Forecast (US$ Mn), By Region, 2013–2030
Figure 76: APEJ Devices Market Volume Forecast (Units), By Region, 2013–2030
Figure 77: APEJ Devices Market Absolute $ Opportunity, 2013–2030 (US$ Mn)
Figure 78: MEA Devices Market Value Forecast (US$ Mn), By Region, 2013–2030
Figure 79: MEA Devices Market Volume Forecast (Units), By Region, 2013–2030
Figure 80: MEA Devices Market Absolute $ Opportunity, 2013–2030 (US$ Mn)
Figure 81: Japan Devices Market Value Forecast (US$ Mn), By Region, 2013–2030
Figure 82: Japan Devices Market Volume Forecast (Units), By Region, 2013–2030
Figure 83: Japan Devices Market Absolute $ Opportunity, 2013–2030 (US$ Mn)
Figure 84: depicts the global devices market value share by regions during the forecast period
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
